← Back to Patent Explorer
US5246708A Expired / Lapsed US ⏱️ 0.0 years remaining

Methods for promoting wound healing with deoxyribonucleosides

Assignee: Pro Neuron Inc
•
Filing: 1992-07-13
•
Granted: 1993-09-21
•
Expires: 2012-07-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Methods are provided for promoting wound healing in animals by administering compositions containing two or more of the following 2'-deoxyribonucleosides: 2'-deoxyadenosine, 2'-deoxyguanosine, 2'-deoxy-cytidine, or thymidine. 3'- and 5'-phosphate derivatives of these 2'-deoxynucleosides are also effective in promoting wound healing.

Inventors

  • 👤 Reid W. von Borstel
  • 👤 Michael K. Bamat

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 18:49
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K45/00; A61K45/06; C; C07; C07H; C07H19/00; C07H19/02; C07H19/04; C07H19/06; C07H19/10

Claims Analysis

Total Claims: 48
Claim 1
Independent Claim 50 words
A method for promoting wound healing comprising administering to an animal possessing a wound a wound healing effective amount of a composition of matter comprising, (a) from 10 to 90 percent by mol 2'-deoxycytidine, and (b) from 90 to 10 percent by mol 2'-deoxyguanosine, or the pharmaceutically acceptable salts thereof.
Claim 2
Independent Claim 50 words
A method for promoting wound healing comprising administering to an animal possessing a wound a wound healing effective amount of a composition of matter comprising, (a) from 10 to 90 percent by mol 2'-deoxycytidine, and (b) from 90 to 10 percent by mol 2'-deoxyguanosine, or the pharmaceutically acceptable salts thereof.
Claim 3
Dependent Claim 21 words
A method as in claim 1 wherein said composition of matter further comprises (c) 2'-deoxyadenosine or a pharmaceutically acceptable salt thereof.
Claim 4
Dependent Claim 21 words
A method as in claim 1 wherein said composition of matter further comprises (c) 2'-deoxythymidine or a pharmaceutically acceptable salt thereof.
Claim 5
Dependent Claim 21 words
A method as in claim 1 wherein said composition of matter further comprises (d) 2'-deoxythymidine or a pharmaceutically acceptable salt thereof.
Claim 6
Independent Claim 72 words
A method for promoting wound healing comprising administering to an animal possessing a wound a wound healing effective amount of a composition of matter comprising, (a) from 10 to 90 percent by mol of a 3'- or 5'-phosphate, or a 3',5'-diphosphate ester of 2'-deoxycytidine, and (b) from 90 to 10 percent by mol of a 3'- or 5'-phosphate, or a 3'- or 5'-diphosphate ester of 2'-deoxyguanosine, or the pharmaceutically acceptable salts thereof.
Claim 7
Independent Claim 72 words
A method for promoting wound healing comprising administering to an animal possessing a wound a wound healing effective amount of a composition of matter comprising, (a) from 10 to 90 percent by mol of a 3'- or 5'-phosphate, or a 3',5'-diphosphate ester of 2'-deoxycytidine, and (b) from 90 to 10 percent by mol of a 3'- or 5'-phosphate, or a 3'- or 5'-diphosphate ester of 2'-deoxyguanosine, or the pharmaceutically acceptable salts thereof.
Claim 8
Dependent Claim 30 words
A method as in claim 5 wherein said composition of matter further comprises (c) a 3'- or 5'-phosphate, or a 3',5'-diphosphate ester of 2'-deoxyadenosine, or a pharmaceutically acceptable salt thereof.
Claim 9
Dependent Claim 30 words
A method as in claim 5 wherein said composition of matter further comprises (c) a 3'- or 5'-phosphate, or a 3',5'-diphosphate ester of 2'-deoxythymidine, or a pharmaceutically acceptable salt thereof.
Claim 10
Dependent Claim 30 words
A method as in claim 6 wherein said composition of matter further comprises (d) a 3'- or 5'-phosphate, or a 3',5'-diphosphate ester of 2'-deoxythymidine, or a pharmaceutically acceptable salt thereof.
Claim 11
Dependent Claim 14 words
A method as in claim 1 or 5 further comprising a pharmaceutically acceptable carrier.
Claim 12
Dependent Claim 15 words
A method as in claim 1 or 5 wherein said wound is a mucosal wound.
Claim 13
Dependent Claim 15 words
A method as in claim 1 or 5 wherein said wound is a dermal wound.
Claim 14
Dependent Claim 15 words
A method as in claim 1 or 5 wherein said wound is a surgical incision.
Claim 15
Dependent Claim 14 words
A method as in claim 1 or 5 wherein said wound is a burn.
Claim 16
Dependent Claim 14 words
A method as in claim 1 or 5 wherein said wound is an ulcer.
Claim 17
Dependent Claim 13 words
A method as in claim 14 wherein said ulcer is a dermal ulcer.
Claim 18
Dependent Claim 13 words
A method as in claim 14 wherein said ulcer is a mucosal ulcer.
Claim 19
Independent Claim 58 words
A method for promoting gastric or duodenal ulcer healing comprising administering to an animal possessing a gastric or duodenal ulcer a gastric or duodenal ulcer-healing effective amount of a composition of matter comprising, (a) from 10 to 90 percent by mol 2'-deoxycytidine, and (b) from 90 to 10 percent by mol 2'-deoxyguanosine, or the pharmaceutically acceptable salts thereof.
Claim 20
Independent Claim 58 words
A method for promoting gastric or duodenal ulcer healing comprising administering to an animal possessing a gastric or duodenal ulcer a gastric or duodenal ulcer-healing effective amount of a composition of matter comprising, (a) from 10 to 90 percent by mol 2'-deoxycytidine, and (b) from 90 to 10 percent by mol 2'-deoxyguanosine, or the pharmaceutically acceptable salts thereof.
Claim 21
Dependent Claim 21 words
A method as in claim 17 wherein said composition of matter further comprises (c) 2'-deoxyadenosine or a pharmaceutically acceptable salt thereof.
Claim 22
Dependent Claim 21 words
A method as in claim 17 wherein said composition of matter further comprises (c) 2'-deoxythymidine or a pharmaceutically acceptable salt thereof.
Claim 23
Dependent Claim 21 words
A method as in claim 18 wherein said composition of matter further comprises (d) 2'-deoxythymidine or a pharmaceutically acceptable salt thereof.
Claim 24
Independent Claim 79 words
A method for promoting gastric or duodenal ulcer healing comprising administering to an animal possessing a gastric or duodenal ulcer a gastric or duodenal ulcer-healing effective amount of a composition of matter comprising, (a) from 10 to 90 percent by mol of a 3'- or 5'-phosphate, or a 3',5'-diphosphate ester of 2'-deoxycytidine, and (b) from 90 to 10 percent by mol of a 3', a 5' phosphate, or a 3',5'-diphosphate ester of 2'-deoxyguanosine, or the pharmaceutically acceptable salts thereof.
Claim 25
Independent Claim 79 words
A method for promoting gastric or duodenal ulcer healing comprising administering to an animal possessing a gastric or duodenal ulcer a gastric or duodenal ulcer-healing effective amount of a composition of matter comprising, (a) from 10 to 90 percent by mol of a 3'- or 5'-phosphate, or a 3',5'-diphosphate ester of 2'-deoxycytidine, and (b) from 90 to 10 percent by mol of a 3', a 5' phosphate, or a 3',5'-diphosphate ester of 2'-deoxyguanosine, or the pharmaceutically acceptable salts thereof.
Claim 26
Dependent Claim 30 words
A method as in claim 21 wherein said composition of matter further comprises (c) a 3'- or 5'-phosphate, or a 3',5'-diphosphate ester of 2'-deoxyadenosine, or a pharmaceutically acceptable salt thereof.
Claim 27
Dependent Claim 30 words
A method as in claim 21 wherein said composition of matter further comprises (c) a 3'- or 5'-phosphate, or a 3',5'-diphosphate ester of 2'-deoxythymidine, or a pharmaceutically acceptable salt thereof.
Claim 28
Dependent Claim 30 words
A method as in claim 22 wherein said composition of matter further comprises (d) a, 3',5' phosphate or a 3', 5'-diphosphate ester of 2'-deoxythymidine, or a pharmaceutically acceptable salt thereof.
Claim 29
Independent Claim 56 words
A method for promoting wound healing comprising administering to an animal possessing a wound a wound healing effective amount of a composition of matter comprising, (a) from 10 to 90 percent by mol 2'-deoxycytidine, and (b) from 90 to 10 percent by mol 2'-deoxyguanosine, or the pharmaceutically acceptable salts thereof, in the form of a liposome.
Claim 30
Independent Claim 56 words
A method for promoting wound healing comprising administering to an animal possessing a wound a wound healing effective amount of a composition of matter comprising, (a) from 10 to 90 percent by mol 2'-deoxycytidine, and (b) from 90 to 10 percent by mol 2'-deoxyguanosine, or the pharmaceutically acceptable salts thereof, in the form of a liposome.
Claim 31
Dependent Claim 21 words
A method as in claim 25 wherein said composition of matter further comprises (c) 2'-deoxyadenosine or a pharmaceutically acceptable salt thereof.
Claim 32
Dependent Claim 21 words
A method as in claim 25 wherein said composition of matter further comprises (c) 2'-deoxythymidine or a pharmaceutically acceptable salt thereof.
Claim 33
Dependent Claim 21 words
A method as in claim 26 wherein said composition of matter further comprises (d) 2'-deoxythymidine or a pharmaceutically acceptable salt thereof.
Claim 34
Independent Claim 76 words
A method for promoting wound healing comprising administering to an animal possessing a wound a wound healing effective amount of a composition of matter comprising, (a) from 10 to 90 percent by mol of a 3'-or 5'-phosphate, or a 3', 5'-diphosphate ester of 2'-deoxycytidine, and (b) from 90 to 10 percent by mol of a 3'-or 5'-phosphate, or a 3', 5'-diphosphate ester of 2'-deoxyguanosine, or the pharmaceutically acceptable salts thereof, in the form of a liposome.
Claim 35
Independent Claim 76 words
A method for promoting wound healing comprising administering to an animal possessing a wound a wound healing effective amount of a composition of matter comprising, (a) from 10 to 90 percent by mol of a 3'-or 5'-phosphate, or a 3', 5'-diphosphate ester of 2'-deoxycytidine, and (b) from 90 to 10 percent by mol of a 3'-or 5'-phosphate, or a 3', 5'-diphosphate ester of 2'-deoxyguanosine, or the pharmaceutically acceptable salts thereof, in the form of a liposome.
Claim 36
Dependent Claim 30 words
A method as in claim 29 wherein said composition of matter further comprises (c) a 3'-or 5'-phosphate, or a 3', 5'-diphosphate ester of 2'-deoxyadenosine, or a pharmaceutically acceptable salt thereof.
Claim 37
Dependent Claim 30 words
A method as in claim 29 wherein said composition of matter further comprises (c) a 3'-or 5'-phosphate, or a 3', 5'-diphosphate ester of 2'-deoxythymidine, or a pharmaceutically acceptable salt thereof.
Claim 38
Dependent Claim 30 words
A method as in claim 30 wherein said composition of matter further comprises (d) a 3'-or 5'-phosphate, or a 3', 5'-diphosphate ester of 2'-deoxythymidine, or a pharmaceutically acceptable salt thereof.
Claim 39
Independent Claim 55 words
A method for promoting wound healing in an animal with corticosteroid-induced impaired wound healing comprising administering to the wound a wound healing effective amount of a composition of matter comprising, (a) from 10 to 90 percent by mol 2'-deoxycytidine, and (b) from 90 to 10 percent by mol 2'-deoxyguanosine, or the pharmaceutically acceptable salts thereof.
Claim 40
Independent Claim 55 words
A method for promoting wound healing in an animal with corticosteroid-induced impaired wound healing comprising administering to the wound a wound healing effective amount of a composition of matter comprising, (a) from 10 to 90 percent by mol 2'-deoxycytidine, and (b) from 90 to 10 percent by mol 2'-deoxyguanosine, or the pharmaceutically acceptable salts thereof.
Claim 41
Dependent Claim 21 words
A method as in claim 33 wherein said composition of matter further comprises (c) 2'-deoxyadenosine or a pharmaceutically acceptable salt thereof.
Claim 42
Dependent Claim 21 words
A method as in claim 33 wherein said composition of matter further comprises (c) 2'-deoxythymidine or a pharmaceutically acceptable salt thereof.
Claim 43
Dependent Claim 21 words
A method as in claim 34 wherein said composition of matter further comprises (d) 2'-deoxythymidine or a pharmaceutically acceptable salt thereof.
Claim 44
Independent Claim 75 words
A method for promoting wound healing in an animal with corticosteroid-induced impaired wound healing comprising administering to the wound a wound healing effective amount of a composition of matter comprising, (a) from 10 to 90 percent by mol of a 3'-or 5'-phosphate, or a 3', 5'-diphosphate ester of 2'-deoxycytidine, and (b) from 90 to 10 percent by mol of a 3'-or 5'-phosphate, or a 3', 5'-diphosphate ester of 2'-deoxyguanosine, or the pharmaceutically acceptable salts thereof.
Claim 45
Independent Claim 75 words
A method for promoting wound healing in an animal with corticosteroid-induced impaired wound healing comprising administering to the wound a wound healing effective amount of a composition of matter comprising, (a) from 10 to 90 percent by mol of a 3'-or 5'-phosphate, or a 3', 5'-diphosphate ester of 2'-deoxycytidine, and (b) from 90 to 10 percent by mol of a 3'-or 5'-phosphate, or a 3', 5'-diphosphate ester of 2'-deoxyguanosine, or the pharmaceutically acceptable salts thereof.
Claim 46
Dependent Claim 30 words
A method as in claim 37 wherein said composition of matter further comprises (c) a 3'-or 5'-phosphate, or a 3', 5'-diphosphate ester of 2'-deoxyadenosine, or a pharmaceutically acceptable salt thereof.
Claim 47
Dependent Claim 30 words
A method as in claim 37 wherein said composition of matter further comprises (c) a 3'-or 5'-phosphate, or a 3', 5'-diphosphate ester of 2'-deoxythymidine, or a pharmaceutically acceptable salt thereof.
Claim 48
Dependent Claim 30 words
A method as in claim 38 wherein said composition of matter further comprises (d) a 3'-or 5'-phosphate, or a 3', 5'-diphosphate ester of 2'-deoxythymidine, or a pharmaceutically acceptable salt thereof.

References Cited (Backward Citations)

CA835941A Cited
US3856776A Cited
US3894000A Cited
US3860706A Cited
US3991045A Cited
US4208406A Cited
US4560678A Cited
US4657896A Cited
US4757139A Cited
GB2152814A Cited
US4758553A Cited
FR2556727A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-09-20 1997-03-22 1997-09-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-09-20 2001-03-22 2001-09-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-09-20 2005-03-22 2005-09-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag